|
Home | Membership Benefits | Seminar
| Resources |
||||
Demo Pages
|
||||
Management of Menopause Type®
Seminar
|
||||
|
|
||||
|
|
|
|||
|
Here is a sample of the Table of Contents that is accessible from every page within the seminar. This table of contents reflects those pages effective on May of 2001. |
||||
|
|
||||
|
In the Management of Menopause Type® Seminar the Table of Contents hyperlink at the bottom of every page allows easy review and navigation within the seminar. |
||||
|
|
||||
|
Within this demo, the Table of Contents hyperlink at the bottom of every page allows easy review and navigation within the demo. |
||||
|
|
||||
|
After viewing this page, please click on the "Next Slide" button to continue with the Demo Pages. |
||||
|
|
||||
Table of Contents
|
||||
References
|
||||
|
Module A - References |
Module D - References |
|||
|
Module B - References |
Module E - References |
|||
|
Module C - References |
Module F - References |
|||
|
|
||||
Module A - Redefining Menopause
|
||||
|
a00 - Introduction |
a17 - Ideal Levels |
|||
|
a01 - Terminology |
a18 - The Physiological Baseline |
|||
|
a02 - What is Menopause - Historical and Social
Perspectives |
a19 - Menopause Type Testing |
|||
|
a03 - Menopause Redefined |
a20 - Actions & Interactions
of Hormones |
|||
|
a04 - Understanding the 12 Menopause Types |
a21 - The Endometrium |
|||
|
a05 - Estradiol - Monthly Activity |
a22 - The Vagina & Urinary
Tract |
|||
|
a06 - Estradiol - Premenopausal Activity |
a23 - The Libido |
|||
|
a07 - Estradiol - Perimenopausal
Activity |
a24 - Blood Sugar & Insulin |
|||
|
a25 - The Brain |
||||
|
a09 - Progesterone - Monthly Activity |
a26 - The Breasts |
|||
|
a10 - Progesterone - Premenopausal Activity |
a27 - The Skin |
|||
|
a11 - Progesterone - Perimenopausal
Activity |
a28 - The Bones |
|||
|
a12 - Progesterone - Postmenopausal Activity |
a29 - The Heart |
|||
|
a13 - Testosterone
- Monthly Activity |
a30 - Risks & Symptoms |
|||
|
a14 - Testosterone
- Premenopausal Activity |
a31 - Modification of Risks
& Symptoms |
|||
|
a15 - Testosterone
- Perimenopausal Activity |
a32 - Compliance & Continuity
of Care |
|||
|
a16 - Testosterone
- Postmenopausal Activity |
a33 - Redefining Menopause -
Review |
|||
|
|
A Ref – Module A - References |
|||
|
b00 - Introduction |
b14 - Case # 1 Step Five |
|||
|
b01 - Subjective Data |
b15 - Case # 1 Step Six |
|||
|
b02 - Estrogen Deficit Symptoms |
b16 - Case # 1 Step Seven |
|||
|
b03 - Progesterone Deficit
Symptoms |
b17 - Case # 1 Step Eight |
|||
|
b04 - Testosterone Deficit
Symptoms |
b18 - Case # 1 Advanced
Interpretation |
|||
|
b05 - Androgen Excess Symptoms |
b19 - Interpreting Subjective Data - Clinical
Applications |
|||
|
b20 - Other Causes of Symptoms - Estrogen Deficit
Symptoms |
||||
|
b07 - Interpreting the MTQ |
b21 - Other Causes of Symptoms - Progesterone
Deficit Symptoms |
|||
|
b08 - Case # 1 |
b22 - Other Causes
of Symptoms - Testosterone Deficit Symptoms |
|||
|
b09 - Case # 1 Fill in Sections
& Columns |
b23 - Other Causes of Symptoms - Androgen Excess
Symptoms |
|||
|
b10 - Case # 1 Step One |
b24 - Therapeutic Interventions Based on Subjective
Data |
|||
|
b11 - Case # 1 Step Two |
b25 - Clinical Applications Case
# 1 |
|||
|
b12 - Case # 1 Step Three |
b26 - Summary of Module B |
|||
|
b13 - Case # 1 Step Four |
B Ref – Module B - References |
|||
Module C - Objective Data
|
||||
|
c00 - Introduction |
c11 - Salivary Hormone Tests -
Clinical Applications |
|||
|
c01 - Objective Data |
c12 - Urinary Hormone Tests - Scientific Literature |
|||
|
c02 - Physical Exam |
c13 - Urine Hormone Tests -
Benefits |
|||
|
c03 - Osteoporosis |
c14 - Urine Hormone Tests -
Limitations |
|||
|
c04 - Cardiovascular Disease |
c15 - Urine Hormone Tests - Clinical Applications |
|||
|
c05 - Cancer Risks |
c16 - Choosing Hormone Tests |
|||
|
c06 - Hormone Tests |
c17 - Diagnostic Goals |
|||
|
c07 - Serum Hormone Tests |
||||
|
c08 - Salivary Hormone Tests Scientific Literature |
c19 - Therapeutic Interventions |
|||
|
c09 - Salivary Hormone Tests -
Benefits |
c20 - Objective Data - Review |
|||
|
c10 - Salivary Hormone Tests - Limitations |
C Ref – Module C - References |
|||
|
|
||||
|
d00 - Introduction |
d07 - Tissue Reaction - Hormone
Levels |
|||
|
d01 - Assessment |
d08 - Tissue Reaction - Agonists or Antagonists |
|||
|
d02 - Defining Assessment |
d09 - Tissue Reaction - Cell
Receptor Sensitivity or Resistance |
|||
|
d03 - Limitations of Subjective
Data |
d10 - Function-Response Model of Tissue Reaction |
|||
|
d04 - Limitations of Objective
Data |
||||
|
d05 - Putting
all the information together - Making an Assessment |
D Ref – Module D - References |
|||
|
d06 - Correlative Interpretation
- The foundation for a Plan |
|
|||
|
|
||||
|
e00 - Introduction |
||||
|
|
Anxiety
& Mood Swings |
|||
|
|
Breasts
Atrophy |
|||
|
|
Protocol for Subjective Type 1 |
|
Hair
Thinning in Women |
|
|
|
Protocol for Subjective Type 2 |
|
Depression |
|
|
|
Protocol for Subjective Type 3 |
|
Dry Skin |
|
|
|
Protocol for Subjective Type 4 |
|
Fatigue |
|
|
|
Protocol for Subjective Type 5 |
|
Headaches |
|
|
|
Protocol for Subjective Type 6 |
|
Heart Palpitations |
|
|
|
Protocol for Subjective Type 7 |
|
Hot Flashes
and/or Night Sweats |
|
|
|
Protocol for Subjective Type 8 |
|
Insomnia |
|
|
|
Protocol for Subjective Type 9 |
|
Libido
Decreased |
|
|
|
Protocol for Subjective Type 10 |
|
Memory Loss &
Difficulty Concentrating |
|
|
|
Protocol for Subjective Type 11 |
|
Urinary
Incontinence |
|
|
|
Protocol for Subjective Type 12 |
|
Vaginal
Bleeding is Irregular |
|
|
e03 - Protocols Based on
Objective Data |
|
Vaginal Pain
or Dryness |
||
|
|
Protocols for Objective Type 1 |
|
Vaginal
Thinning/Atrophy |
|
|
|
Protocols for Objective Type 2 |
e05 - Protocols to Support Body Systems |
||
|
|
Protocols for Objective Type 3 |
|
Colon Cancer |
|
|
|
Protocols for Objective Type 4 |
|
Dementia / Alzheimer’s |
|
|
|
Protocols for Objective Type 5 |
|
Diabetes / Insulin
Resistance |
|
|
|
Protocols for Objective Type 6 |
|
Heart Disease |
|
|
|
Protocols for Objective Type 7 |
|
Osteoporosis |
|
|
|
Protocols for Objective Type 8 |
|
Tooth
Loss
|
|
|
|
Protocols for Objective Type 9 |
e06 - Merging Protocols Into A Treatment Plan |
||
|
|
Protocols for Objective Type 10 |
e07 - Plan - Review |
||
|
|
Protocols for Objective Type 11 |
E Ref – Module E References |
||
|
|
Protocols for Objective Type 12 |
|
||
|
|
||||
|
f00 - Introduction |
f10 - Session 6 - Eight Months |
|||
|
f01 - Implement - Evaluate – Reassess |
f11 - Session 7- Eleven Months |
|||
|
f02 - Comprehensive Health Care |
f12 - Session 8 - Twelve Months |
|||
|
f03 - Continuity of Care |
f13 - Session 9 - Eighteen
Months |
|||
|
f14 - Session 10 - Nineteen
Months |
||||
|
f05 - Session 1 - Initial Visit |
f15 - Session 11 - 25 to 31
months |
|||
|
f06 - Session 2 - One Month Later |
f16 - Session 12+ - Continue Yearly Evaluations |
|||
|
f07 - Session 3 - Three Months |
f17 - Implement - Evaluate -
Reassess - Review |
|||
|
f08 - Session 4 - Five Months |
F Ref – Module F References |
|||
|
f09 - Session 5 - Six Months |
|
|||
|
|
||||
|
Clinicians Automated Review Educational Quiz & Registration
Form |
||||
|
C.A.R.E. Quiz may be taken only
after completing the on-line seminar. |
Registration Form may be
completed only after taking the C.A.R.E. Quiz. |
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
YourMenopauseType.com, Inc. |
||||
